Top section
Top section
Deeply discounted financing allows embattled iron ore miner to restart Ukrainian production and shares to resume trading
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Centralisation, competitiveness and cyber-risk will be political flashpoints
More articles
More articles
More articles
-
GenSight Biologics, a niche French biotechnology firm focused on treating degenerative retinal and nervous system disorders, has completed its all-primary IPO on Euronext Paris, raising €46m to help bring its flagship drug GS010 to market in Europe and the US. -
One of the most senior women in JP Morgan’s European investment banking division has quit to join a private equity fund.
-
UniCredit has dominated the headlines again this week, but this time for a better reason. Italy’s largest bank has also been its biggest loser of shareholder value, its shares falling 75% since last summer, as investors have lost trust in the sector.
-
Shandong International Trust Corp, which is planning a $300m Hong Kong listing, is set to ask for approval for the deal in September, according to a source familiar with matter.
-
EC World Real Estate Investment Trust has opened books on its S$350.7m ($260.1m) listing in Singapore, as investors continue to flock to the relative safety of Reits and amid a hunt for yield.
-
Chinese logistics firm ZTO Express is seeking approval for an IPO in the US that could raise up to $2bn, according to a source familiar with the matter.
Sub-sections
shared comment list
